Squarepoint Ops LLC Takes $104,000 Position in Hookipa Pharma Inc (NASDAQ:HOOK)

Squarepoint Ops LLC acquired a new stake in shares of Hookipa Pharma Inc (NASDAQ:HOOK) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 51,960 shares of the company’s stock, valued at approximately $104,000. Squarepoint Ops LLC owned 0.43% of Hookipa Pharma as of its most recent filing with the Securities and Exchange Commission (SEC).

Separately, Millennium Management LLC purchased a new stake in Hookipa Pharma in the fourth quarter worth $31,000. 63.88% of the stock is currently owned by institutional investors.

Hookipa Pharma Stock Down 1.9%

Shares of HOOK stock opened at $1.53 on Tuesday. The stock has a fifty day moving average of $1.19 and a 200 day moving average of $1.60. Hookipa Pharma Inc has a 52 week low of $0.72 and a 52 week high of $8.25. The firm has a market capitalization of $18.65 million, a price-to-earnings ratio of -0.41 and a beta of 0.96.

Hookipa Pharma (NASDAQ:HOOK) last issued its quarterly earnings results on Thursday, May 15th. The company reported ($1.23) earnings per share for the quarter, missing the consensus estimate of ($0.61) by ($0.62). Hookipa Pharma had a negative net margin of 86.74% and a negative return on equity of 33.31%. Equities research analysts anticipate that Hookipa Pharma Inc will post -1.75 earnings per share for the current year.

About Hookipa Pharma

HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.